Law Firm Turns Opioid Case Fees Into Securities for Investors, Shifting Legal Landscape
In a bold move that blurs the lines between legal practice and financial innovation, a New York-based law firm is transforming its future legal fees from opioid litigation into securities for investment. Napoli Shkolnik PLLC, a prominent player in mass tort litigation, has packaged its anticipated earnings from approximately $1.3 billion in settlements with opioid manufacturers and pharmacies—including giants like McKesson, Janssen, CVS, and Walgreens—into a new financial product. These settlements, detailed in a Securities and Exchange Commission filing, mark the company’s strategy to monetize anticipated profits upfront. This approach reflects a growing trend where … Read more